SAG
FLNA

Spotlight Asset Group’s Filana Therapeutics FLNA Stock Holding History

Spotlight Asset Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.59K Hold
210
– – ﹤0.01% 237
2024
Q1 		$4.26K Hold
210
– – ﹤0.01% 224
2023
Q4 		$3.49K Hold
210
– – ﹤0.01% 221
2023
Q3 		$3.49K Hold
210
– – ﹤0.01% 221
2023
Q2 		$5.15K Buy
+210
New +$5.06K ﹤0.01% 220

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Spotlight Asset Group's FLNA Position: Q2 2024 in Review

Spotlight Asset Group held its Filana Therapeutics (FLNA) position steady in Q2 2024 at 210 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

Spotlight Asset Group first reported a position in FLNA in Q2 2023 and has held it in 5 quarters since. The position peaked at $5.15K in Q2 2023. 145 funds tracked by Wall St. Rank hold FLNA as of Q2 2024.

  • Spotlight Asset Group held 210 shares of Filana Therapeutics worth $2.59K as of Q2 2024.
  • Spotlight Asset Group left its Filana Therapeutics share count unchanged in Q2 2024.
  • Filana Therapeutics made up ﹤0.01% of Spotlight Asset Group's portfolio in Q2 2024, its #237 holding.
  • Spotlight Asset Group first reported a position in Filana Therapeutics in Q2 2023 and has held it in 5 quarters since.
  • Spotlight Asset Group's Filana Therapeutics position peaked at $5.15K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.